Home Cart Sign in  
Chemical Structure| 1527503-11-2 Chemical Structure| 1527503-11-2

Structure of A-366
CAS No.: 1527503-11-2

Chemical Structure| 1527503-11-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

A-366 is a peptide-competitive inhibitor of G9a/GLP with IC50 of ~3 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of A-366

CAS No. :1527503-11-2
Formula : C19H27N3O2
M.W : 329.44
SMILES Code : NC(C12CCC1)=NC3=C2C=C(OC)C(OCCCN4CCCC4)=C3
MDL No. :MFCD28133403
InChI Key :BKCDJTRMYWSXMC-UHFFFAOYSA-N
Pubchem ID :76285486

Safety of A-366

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of A-366

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U2OS cells 10μM 6 days A-366 significantly hypersensitized U2OS cells to phleomycin, inhibiting tumor cell growth. PMC5011428
Primary neurons 2 µM 12 days Inhibition of EHMT1/2, reduction of H3K9me2 levels, restoration of synaptic protein expression PMC10933175
HEK293-α-syn-GFP cells 2 µM 48 h Inhibition of EHMT1/2, reduction of H3K9me2 levels, restoration of synaptic protein expression PMC10933175

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice C57BL/6 mice Intraperitoneal injection 1 or 2 mg/kg Daily for 14 days Chronic A-366 treatment decreased anxiety-like behaviors and reduced brain H3K9me2 levels. PMC5943902
C57BL/6J mice PD mouse model Intraperitoneal injection 2 mg/kg Every 3 days for 5 months Inhibition of EHMT1/2, reduction of H3K9me2 levels, improvement of motor deficits and synaptic damage PMC10933175
Mice Photothrombotic stroke model Intraperitoneal injection 2 mg/kg Once a day for 7 days A-366 protected penumbra cells from apoptosis and reduced the volume of PTS-induced cerebral infarction PMC8619375

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.04mL

0.61mL

0.30mL

15.18mL

3.04mL

1.52mL

30.35mL

6.07mL

3.04mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories